Related Experiment Video
Updated: Aug 9, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Management of hypercholesterolemia: practice patterns for primary care providers and cardiologists
1Heart Institute of St. Petersburg, Florida 33707, USA.
Insights
Patients with coronary artery disease (CAD) receive better care for lowering LDL cholesterol in specialized lipid clinics. These clinics improve documentation and treatment adherence to national guidelines for secondary prevention.
Area of Science:
- Cardiology
- Preventive Medicine
- Health Services Research
Background:
- Coronary Artery Disease (CAD) management requires optimal lipid control.
- National Cholesterol Education Program (NCEP II) guidelines set LDL cholesterol goals for CAD patients.
- Quality assurance processes are vital for evaluating care delivery.
Purpose of the Study:
- To compare lipid management practices for CAD patients in a dedicated lipid clinic versus general non-lipid clinic settings.
- To assess adherence to NCEP II low-density lipoprotein (LDL) cholesterol goals.
- To identify disparities in care based on clinic setting and physician specialty.
Main Methods:
- Retrospective chart review of 934 CAD patients (ICD-9 codes 410-414).
- Evaluation of quality assurance parameters: LDL cholesterol documentation, lipid-lowering therapy initiation, and NCEP II goal achievement (< or =100 mg/dL).
- Comparison of care between LIFEHELP lipid clinic and non-lipid clinic settings, including physician specialty.
Main Results:
- Lipid clinics demonstrated higher rates of LDL cholesterol documentation and achievement of NCEP II goals.
- Within non-lipid clinics, cardiologists showed better lipid management than primary care physicians.
- Women and elderly patients benefited from improved care in the lipid clinic setting.
Conclusions:
- Specialized lipid clinics enhance the standard of care for secondary prevention in CAD patients.
- Lipid clinics facilitate closer adherence to national guidelines for LDL cholesterol management.
- Optimized screening and risk-factor management are key benefits of lipid clinic care.
Abstract:
This retrospective study, conducted as part of a private practice quality assurance process for patients with coronary artery disease (CAD), compares practice patterns in the LIFEHELP lipid clinic and non-lipid clinic settings at the Heart Institute of St. Petersburg. Quality assurance parameters included documentation of low-density lipoprotein (LDL) cholesterol, initiation of lipid-lowering therapy, and achievement of the Second National Cholesterol Education Program (NCEP II) goal for CAD patients of LDL cholesterol < or =100 mg/dL. A total of 934 patient charts with ICD-9 codes of 410-414 for ischemic heart disease were randomly selected and reviewed by a utilization review nurse. A higher level of documentation and treatment of elevated LDL cholesterol to NCEP II goal in CAD patients was found for those followed in the lipid clinic. Among non-lipid clinic physicians, cardiologists documented and treated elevated LDL cholesterol more frequently than primary care physicians. Women and the elderly subgroups received improved care in the lipid clinic setting. Screening activities and risk-factor management by cardiologists within a lipid clinic, therefore, demonstrated an improved standard of care that came closer to achieving national guidelines in the secondary prevention of CAD.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Atherosclerosis III: Management

